Vbi Vaccines Inc CS (VBIV)
$2.61 0.08 (3.16%)
19:59 EDT VBIV Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 167.25M
PE Ratio -
Volume (Avg. Vol.) 4.15M
Day's Range 2.48 - 2.65
52-Week Range 0.53 - 6.93
Dividend & Yield N/A (N/A)
VBIV Stock Predictions, Articles, and Vbi Vaccines Inc CS News
- From InvestorPlace
- From the Web
It wasn’t just toilet paper that was in demand when Covid-19 hit us as short-term stocks flew through the roof. But with a second wave upon us, this narrative looks very compelling.
By Thomas Niel
Sci-B-Vac's success will make or break VBIV stock. But the shares' recent pullback may have created a great buying opportunity.
While some argue you get what you pay for, others say that stocks trading at low levels can represent compelling opportunities.
VBI Vaccines (VBIV) news for Monday about results from a recent clinical trial of a hepatitis B vaccine have VBI stock soaring.
Here's a look at three biotech stocks that have at least one treatment prepped to enter pivotal clinical trials soon.
From The Motley Fool
From Market News Video
Investors in VBI Vaccines Inc (VBIV) saw new options begin trading this week, for the December 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VBIV options chain for the new December 18th contracts and identified one put and one call contract of particular interest.
Navellier RatingsPowered by Portfolio Grader